NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
Q4289 Revoshield + amniotic barrier, per square centimeter HCPCS · Medical/Surgical Supplies dme
Classification DME Medical/Surgical Supplies Skin Allograft (CMS RBCS)
First observed 2024
National scale 8,216 services · est. · 119 FFS beneficiaries (CY2024, all-Medicare estimate) — 4,601 observed fee-for-service services
Medicare paid $13.2M · est. · $1642.65 avg / service, national — $7.6M observed FFS
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

3

Named groups billing this code
Named-group all-Medicare svcs · est.

4,385

Scaled from 2,187 observed FFS services.
FFS of Medicare

49%

Payer-mix frame
Services YoY

Estimated all-Medicare volume estimate
FFS + estimated MA

~4,385 services

2,187 observed fee-for-service (50%) · ~2,198 estimated Medicare Advantage.

Billing for this code concentrates in one state — scaled by the national payer mix (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — Q4289 (CY2024)

Est. all-Medicare services by billing state (scaled estimate — assumes MA utilization mirrors FFS); open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$5.0M
Named-group allowed amount
$4.6M
Named-group Medicare payments
$7.3M · est.
— $3.6M observed FFS
Avg charge / svc
$2,276
Avg allowed / svc
$2,088
Avg payment / svc
$1,663
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$1,848 3 groups · avg submitted charge / service $4,337
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — each panel renders gated on the free tier.

See it in full: nuclear heart imaging (78452) in Arizona is open as a live example — every paid panel, on real data.

View the live example →
See the Platform — the full read, every number below, code baskets, and export. Notify me at launch →
Refine: group size any 5+ locked column25+ locked column100+ locked column independent only locked column
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by Q4289 services, highest first, CY2024
# Physician group locked column City locked column St locked column Specialty locked column Providers locked column Q4289 svcs Submitted charges locked column Avg charge locked column Medicare $ locked column Share of state* locked column Phone
1 SOUTHEASTERN DERMATOLOGY GROUP PA PANAMA CITY FL PHYSICIAN ASSISTANT 43 1,206 $2,229,250 $1,848 premium 100.0%
2 MARYLAND GENERAL CLINICAL PRACTICE GROUP, INC. BALTIMORE MD NURSE PRACTITIONER 61 859 $2,218,720 $2,583 premium 100.0% (410) 225-8446
3 SAINTS MEDICAL GROUP, LLC OKLAHOMA CITY OK PHYSICIAN ASSISTANT 435 122 $529,100 $4,337 premium 100.0%

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix — and the observed foundation every market figure here builds on. Market totals anchor on a labeled all-Medicare estimate scaled from that foundation, with the observed count disclosed beside it — Medicare only, never all-payer. Modeled all-payer databases project every payer statistically and typically run higher. Same market, different denominator. How the numbers reconcile →